SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 135 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,000 | -96.6% | 111 | -97.8% | 0.00% | -100.0% |
Q3 2017 | $59,000 | +1375.0% | 4,970 | +1357.5% | 0.01% | – |
Q2 2017 | $4,000 | -42.9% | 341 | -40.6% | 0.00% | -100.0% |
Q4 2016 | $7,000 | +600.0% | 574 | +468.3% | 0.00% | – |
Q3 2016 | $1,000 | -90.9% | 101 | -89.6% | 0.00% | -100.0% |
Q2 2016 | $11,000 | -82.3% | 972 | -73.1% | 0.00% | -90.0% |
Q4 2015 | $62,000 | +93.8% | 3,612 | +121.2% | 0.01% | +233.3% |
Q3 2015 | $32,000 | +52.4% | 1,633 | +26.6% | 0.00% | +50.0% |
Q2 2015 | $21,000 | +425.0% | 1,290 | +409.9% | 0.00% | – |
Q1 2015 | $4,000 | -42.9% | 253 | -51.1% | 0.00% | -100.0% |
Q4 2014 | $7,000 | -56.2% | 517 | -78.3% | 0.00% | -50.0% |
Q3 2014 | $16,000 | +300.0% | 2,387 | +329.3% | 0.00% | +100.0% |
Q2 2014 | $4,000 | -20.0% | 556 | -33.3% | 0.00% | 0.0% |
Q3 2013 | $5,000 | -84.8% | 834 | -83.3% | 0.00% | -66.7% |
Q2 2013 | $33,000 | – | 4,995 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |